Company / EPS (Diluted)
Vivani Medical, Inc. EPS (Diluted) History
FY2015-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.56
FY2017
5-year range
-$1.41 / -$0.56
FY2015-FY2017
Trend
+60.3%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-1.02 to $-0.56 over the past 2 years.
Based on SEC 10-K filings.
-0.56 in FY2017.
Improved from $-1.02 to $-0.56 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, eps (diluted) increased 60.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -4.83 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2017 | -$0.56 | +60.3% |
| FY2016 | -$1.41 | -38.2% |
| FY2015 | -$1.02 | - |
As of FY2017 · SEC 10-K · Updated Jun 28, 2026